Braskem sets 2026 annual shareholder meeting date
Braskem S.A. filed a report as a foreign private issuer to inform shareholders that its Annual General Meeting is scheduled for April 29, 2026, following its Annual Corporate Events Calendar.
Rhea-AI Filing Summary
Braskem S.A. filed a report as a foreign private issuer to inform shareholders that its Annual General Meeting is scheduled for April 29, 2026, following its Annual Corporate Events Calendar. The company notes that detailed participation guidelines and formal meeting materials will be provided later, within the required legal timeframe and regulations. Shareholders can request further information from Braskem’s Investor Relations team by phone or email.
Positive
- None.
Negative
- None.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
When will Braskem (BAK) hold its 2026 Annual General Meeting?
Braskem’s Annual General Meeting is scheduled to take place on April 29, 2026, in line with its Annual Corporate Events Calendar.
What is the purpose of this Braskem (BAK) Form 6-K filing?
The filing serves to notify shareholders of the date of Braskem’s 2026 Annual General Meeting and to state that detailed participation guidelines and call materials will be provided within the legal deadline.
Does Braskem (BAK) provide any meeting materials with this AGM date notice?
No detailed materials are included with this notice. Braskem states that the guidelines for participation and the call material will be made available later, within the applicable legal deadline.
Does the Braskem (BAK) Form 6-K include any financial results or earnings data?
No. This particular Form 6-K focuses on announcing the date of the Annual General Meeting and includes a standard forward-looking statements disclaimer, but does not present financial results.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT
TO RULE 13A-16
OR 15D-16 OF THE SECURITIES EXCHANGE ACT OF 1934
For the month of January, 2026
(Commission File No. 1-14862 )
BRASKEM S.A.
(Exact Name as Specified in its Charter)
N/A
(Translation of registrant's name into English)
Rua Eteno, 1561, Polo Petroquimico de Camacari
Camacari, Bahia - CEP 42810-000 Brazil
(Address of principal executive offices)
Indicate by check mark whether the registrant
files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ___X___ Form 40-F ______
Indicate by check mark if the registrant is
submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(1). _____
Indicate by check mark if the registrant is
submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(7). _____
Indicate by check mark whether the
registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant
to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes ______ No ___X___
If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- _____.
NOTICE TO THE SHAREHOLDERS
DATE OF THE ANNUAL GENERAL MEETING
In compliance with to Article 37, § 2 of CVM Resolution No. 81/22, Braskem S.A. (“Braskem” or “Company”) hereby informs that the Company’s Annual General Meeting is scheduled to be held on April 29, 2026, in accordance with its Annual Corporate Events Calendar.
The guidelines for participation, as well as the call material, will be made available in due course, within the legal deadline and the applicable regulations. Further information can be obtained from the Company’s Investor Relations Department, by phone at +55 (11) 3576-9531 or by email at braskem-ri@braskem.com.br.
São Paulo, January 14, 2026.
Felipe Montoro Jens
Chief Financial and Investor Relations Officer
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: January 14, 2026
| BRASKEM S.A. | |||
| By: | /s/ Felipe Montoro Jens | ||
| Name: | Felipe Montoro Jens | ||
| Title: | Chief Financial Officer | ||
DISCLAIMER ON FORWARD-LOOKING STATEMENTS
This report on Form 6-K may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are statements that are not historical facts, and are based on our management’s current view and estimates of future economic and other circumstances, industry conditions, company performance and financial results, including any potential or projected impact of the geological event in Alagoas and related legal proceedings and of COVID-19 on our business, financial condition and operating results. The words “anticipates,” “believes,” “estimates,” “expects,” “plans” and similar expressions, as they relate to the company, are intended to identify forward-looking statements. Statements regarding the potential outcome of legal and administrative proceedings, the implementation of principal operating and financing strategies and capital expenditure plans, the direction of future operations and the factors or trends affecting our financial condition, liquidity or results of operations are examples of forward-looking statements. Such statements reflect the current views of our management and are subject to a number of risks and uncertainties, many of which are outside of the our control. There is no guarantee that the expected events, trends or results will actually occur. The statements are based on many assumptions and factors, including general economic and market conditions, industry conditions, and operating factors. Any changes in such assumptions or factors, including the projected impact of the geological event in Alagoas and related legal proceedings and the unprecedented impact of COVID-19 pandemic on our business, employees, service providers, stockholders, investors and other stakeholders, could cause actual results to differ materially from current expectations. Please refer to our annual report on Form 20-F for the year ended December 31, 2019 filed with the SEC, as well as any subsequent filings made by us pursuant to the Exchange Act, each of which is available on the SEC’s website (www.sec.gov), for a full discussion of the risks and other factors that may impact any forward-looking statements in this presentation.